Report Detail

Pharma & Healthcare 2018-2023 Global Gastrointestinal Drugs Consumption Market Report

  • RnM2475710
  • |
  • 12 October, 2018
  • |
  • Global
  • |
  • 159 pages
  • |
  • LPI(LP Information)
  • |
  • Pharma & Healthcare

2018-2023 Global Gastrointestinal Drugs Consumption Market Report

Table of Contents

    2018-2023 Global Gastrointestinal Drugs Consumption Market Report

      1 Scope of the Report

      • 1.1 Market Introduction
      • 1.2 Research Objectives
      • 1.3 Years Considered
      • 1.4 Market Research Methodology
      • 1.5 Economic Indicators
      • 1.6 Currency Considered

      2 Executive Summary

      • 2.1 World Market Overview
        • 2.1.1 Global Gastrointestinal Drugs Consumption 2013-2023
        • 2.1.2 Gastrointestinal Drugs Consumption CAGR by Region
      • 2.2 Gastrointestinal Drugs Segment by Type
        • 2.2.1 Prescription Gastrointestinal Drug
        • 2.2.2 OTC Gastrointestinal Drug
      • 2.3 Gastrointestinal Drugs Consumption by Type
        • 2.3.1 Global Gastrointestinal Drugs Consumption Market Share by Type (2013-2018)
        • 2.3.2 Global Gastrointestinal Drugs Revenue and Market Share by Type (2013-2018)
        • 2.3.3 Global Gastrointestinal Drugs Sale Price by Type (2013-2018)
      • 2.4 Gastrointestinal Drugs Segment by Application
        • 2.4.1 Chronic Gastritis
        • 2.4.2 Functional Dyspepsia
        • 2.4.3 Peptic Ulcer
        • 2.4.4 Acute Gastroenteritis
        • 2.4.5 Other
      • 2.5 Gastrointestinal Drugs Consumption by Application
        • 2.5.1 Global Gastrointestinal Drugs Consumption Market Share by Application (2013-2018)
        • 2.5.2 Global Gastrointestinal Drugs Value and Market Share by Application (2013-2018)
        • 2.5.3 Global Gastrointestinal Drugs Sale Price by Application (2013-2018)

      3 Global Gastrointestinal Drugs by Players

      • 3.1 Global Gastrointestinal Drugs Sales Market Share by Players
        • 3.1.1 Global Gastrointestinal Drugs Sales by Players (2016-2018)
        • 3.1.2 Global Gastrointestinal Drugs Sales Market Share by Players (2016-2018)
      • 3.2 Global Gastrointestinal Drugs Revenue Market Share by Players
        • 3.2.1 Global Gastrointestinal Drugs Revenue by Players (2016-2018)
        • 3.2.2 Global Gastrointestinal Drugs Revenue Market Share by Players (2016-2018)
      • 3.3 Global Gastrointestinal Drugs Sale Price by Players
      • 3.4 Global Gastrointestinal Drugs Manufacturing Base Distribution, Sales Area, Product Types by Players
        • 3.4.1 Global Gastrointestinal Drugs Manufacturing Base Distribution and Sales Area by Players
        • 3.4.2 Players Gastrointestinal Drugs Products Offered
      • 3.5 Market Concentration Rate Analysis
        • 3.5.1 Competition Landscape Analysis
        • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2016-2018)
      • 3.6 New Products and Potential Entrants
      • 3.7 Mergers & Acquisitions, Expansion

      4 Gastrointestinal Drugs by Regions

      • 4.1 Gastrointestinal Drugs by Regions
        • 4.1.1 Global Gastrointestinal Drugs Consumption by Regions
        • 4.1.2 Global Gastrointestinal Drugs Value by Regions
      • 4.2 Americas Gastrointestinal Drugs Consumption Growth
      • 4.3 APAC Gastrointestinal Drugs Consumption Growth
      • 4.4 Europe Gastrointestinal Drugs Consumption Growth
      • 4.5 Middle East & Africa Gastrointestinal Drugs Consumption Growth

      5 Americas

      • 5.1 Americas Gastrointestinal Drugs Consumption by Countries
        • 5.1.1 Americas Gastrointestinal Drugs Consumption by Countries (2013-2018)
        • 5.1.2 Americas Gastrointestinal Drugs Value by Countries (2013-2018)
      • 5.2 Americas Gastrointestinal Drugs Consumption by Type
      • 5.3 Americas Gastrointestinal Drugs Consumption by Application
      • 5.4 United States
      • 5.5 Canada
      • 5.6 Mexico
      • 5.7 Key Economic Indicators of Few Americas Countries

      6 APAC

      • 6.1 APAC Gastrointestinal Drugs Consumption by Countries
        • 6.1.1 APAC Gastrointestinal Drugs Consumption by Countries (2013-2018)
        • 6.1.2 APAC Gastrointestinal Drugs Value by Countries (2013-2018)
      • 6.2 APAC Gastrointestinal Drugs Consumption by Type
      • 6.3 APAC Gastrointestinal Drugs Consumption by Application
      • 6.4 China
      • 6.5 Japan
      • 6.6 Korea
      • 6.7 Southeast Asia
      • 6.8 India
      • 6.9 Australia
      • 6.10 Key Economic Indicators of Few APAC Countries

      7 Europe

      • 7.1 Europe Gastrointestinal Drugs by Countries
        • 7.1.1 Europe Gastrointestinal Drugs Consumption by Countries (2013-2018)
        • 7.1.2 Europe Gastrointestinal Drugs Value by Countries (2013-2018)
      • 7.2 Europe Gastrointestinal Drugs Consumption by Type
      • 7.3 Europe Gastrointestinal Drugs Consumption by Application
      • 7.4 Germany
      • 7.5 France
      • 7.6 UK
      • 7.7 Italy
      • 7.8 Russia
      • 7.9 Spain
      • 7.10 Key Economic Indicators of Few Europe Countries

      8 Middle East & Africa

      • 8.1 Middle East & Africa Gastrointestinal Drugs by Countries
        • 8.1.1 Middle East & Africa Gastrointestinal Drugs Consumption by Countries (2013-2018)
        • 8.1.2 Middle East & Africa Gastrointestinal Drugs Value by Countries (2013-2018)
      • 8.2 Middle East & Africa Gastrointestinal Drugs Consumption by Type
      • 8.3 Middle East & Africa Gastrointestinal Drugs Consumption by Application
      • 8.4 Egypt
      • 8.5 South Africa
      • 8.6 Israel
      • 8.7 Turkey
      • 8.8 GCC Countries

      9 Market Drivers, Challenges and Trends

      • 9.1 Market Drivers and Impact
        • 9.1.1 Growing Demand from Key Regions
        • 9.1.2 Growing Demand from Key Applications and Potential Industries
      • 9.2 Market Challenges and Impact
      • 9.3 Market Trends

      10 Marketing, Distributors and Customer

      • 10.1 Sales Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
      • 10.2 Gastrointestinal Drugs Distributors
      • 10.3 Gastrointestinal Drugs Customer

      11 Global Gastrointestinal Drugs Market Forecast

      • 11.1 Global Gastrointestinal Drugs Consumption Forecast (2018-2023)
      • 11.2 Global Gastrointestinal Drugs Forecast by Regions
        • 11.2.1 Global Gastrointestinal Drugs Forecast by Regions (2018-2023)
        • 11.2.2 Global Gastrointestinal Drugs Value Forecast by Regions (2018-2023)
        • 11.2.3 Americas Consumption Forecast
        • 11.2.4 APAC Consumption Forecast
        • 11.2.5 Europe Consumption Forecast
        • 11.2.6 Middle East & Africa Consumption Forecast
      • 11.3 Americas Forecast by Countries
        • 11.3.1 United States Market Forecast
        • 11.3.2 Canada Market Forecast
        • 11.3.3 Mexico Market Forecast
        • 11.3.4 Brazil Market Forecast
      • 11.4 APAC Forecast by Countries
        • 11.4.1 China Market Forecast
        • 11.4.2 Japan Market Forecast
        • 11.4.3 Korea Market Forecast
        • 11.4.4 Southeast Asia Market Forecast
        • 11.4.5 India Market Forecast
        • 11.4.6 Australia Market Forecast
      • 11.5 Europe Forecast by Countries
        • 11.5.1 Germany Market Forecast
        • 11.5.2 France Market Forecast
        • 11.5.3 UK Market Forecast
        • 11.5.4 Italy Market Forecast
        • 11.5.5 Russia Market Forecast
        • 11.5.6 Spain Market Forecast
      • 11.6 Middle East & Africa Forecast by Countries
        • 11.6.1 Egypt Market Forecast
        • 11.6.2 South Africa Market Forecast
        • 11.6.3 Israel Market Forecast
        • 11.6.4 Turkey Market Forecast
        • 11.6.5 GCC Countries Market Forecast
      • 11.7 Global Gastrointestinal Drugs Forecast by Type
      • 11.8 Global Gastrointestinal Drugs Forecast by Application

      12 Key Players Analysis

      • 12.1 AstraZeneca
        • 12.1.1 Company Details
        • 12.1.2 Gastrointestinal Drugs Product Offered
        • 12.1.3 AstraZeneca Gastrointestinal Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
        • 12.1.4 Main Business Overview
        • 12.1.5 AstraZeneca News
      • 12.2 Sanofi
        • 12.2.1 Company Details
        • 12.2.2 Gastrointestinal Drugs Product Offered
        • 12.2.3 Sanofi Gastrointestinal Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
        • 12.2.4 Main Business Overview
        • 12.2.5 Sanofi News
      • 12.3 Bayer
        • 12.3.1 Company Details
        • 12.3.2 Gastrointestinal Drugs Product Offered
        • 12.3.3 Bayer Gastrointestinal Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
        • 12.3.4 Main Business Overview
        • 12.3.5 Bayer News
      • 12.4 Pfizer
        • 12.4.1 Company Details
        • 12.4.2 Gastrointestinal Drugs Product Offered
        • 12.4.3 Pfizer Gastrointestinal Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
        • 12.4.4 Main Business Overview
        • 12.4.5 Pfizer News
      • 12.5 GlaxoSmithKline
        • 12.5.1 Company Details
        • 12.5.2 Gastrointestinal Drugs Product Offered
        • 12.5.3 GlaxoSmithKline Gastrointestinal Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
        • 12.5.4 Main Business Overview
        • 12.5.5 GlaxoSmithKline News
      • 12.6 Teva
        • 12.6.1 Company Details
        • 12.6.2 Gastrointestinal Drugs Product Offered
        • 12.6.3 Teva Gastrointestinal Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
        • 12.6.4 Main Business Overview
        • 12.6.5 Teva News
      • 12.7 Zeria(Tillotts)
        • 12.7.1 Company Details
        • 12.7.2 Gastrointestinal Drugs Product Offered
        • 12.7.3 Zeria(Tillotts) Gastrointestinal Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
        • 12.7.4 Main Business Overview
        • 12.7.5 Zeria(Tillotts) News
      • 12.8 Perrigo
        • 12.8.1 Company Details
        • 12.8.2 Gastrointestinal Drugs Product Offered
        • 12.8.3 Perrigo Gastrointestinal Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
        • 12.8.4 Main Business Overview
        • 12.8.5 Perrigo News
      • 12.9 Boehringer Ingelheim
        • 12.9.1 Company Details
        • 12.9.2 Gastrointestinal Drugs Product Offered
        • 12.9.3 Boehringer Ingelheim Gastrointestinal Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
        • 12.9.4 Main Business Overview
        • 12.9.5 Boehringer Ingelheim News
      • 12.10 Purdue Pharma
        • 12.10.1 Company Details
        • 12.10.2 Gastrointestinal Drugs Product Offered
        • 12.10.3 Purdue Pharma Gastrointestinal Drugs Sales, Revenue, Price and Gross Margin (2016-2018)
        • 12.10.4 Main Business Overview
        • 12.10.5 Purdue Pharma News
      • 12.11 C.B. Fleet
      • 12.12 Abbott
      • 12.13 Jiangzhong
      • 12.14 Xian-Janssen

      13 Research Findings and Conclusion

      In this report, LP Information covers the present scenario (with the base year being 2017) and the growth prospects of global Gastrointestinal Drugs market for 2018-2023.

      Gastrointestinal (GI) disorders include functional bowel diseases such as irritable bowel syndrome (IBS) and inflammatory bowel diseases such as Crohn's disease (CD) and colitis. Some gastrointestinal drug can control or moderate the symptoms of gastrointestinal disorders.
      Over the next five years, LPI(LP Information) projects that Gastrointestinal Drugs will register a xx% CAGR in terms of revenue, reach US$ xx million by 2023, from US$ xx million in 2017.

      This report presents a comprehensive overview, market shares, and growth opportunities of Gastrointestinal Drugs market by product type, application, key manufacturers and key regions.

      To calculate the market size, LP Information considers value and volume generated from the sales of the following segments:

      Segmentation by product type:
      Prescription Gastrointestinal Drug
      OTC Gastrointestinal Drug
      Segmentation by application:
      Chronic Gastritis
      Functional Dyspepsia
      Peptic Ulcer
      Acute Gastroenteritis
      Other

      This report also splits the market by region:
      Americas
      United States
      Canada
      Mexico
      Brazil
      APAC
      China
      Japan
      Korea
      Southeast Asia
      India
      Australia
      Europe
      Germany
      France
      UK
      Italy
      Russia
      Spain
      Middle East & Africa
      Egypt
      South Africa
      Israel
      Turkey
      GCC Countries

      The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report:
      AstraZeneca
      Sanofi
      Bayer
      Pfizer
      GlaxoSmithKline
      Teva
      Zeria(Tillotts)
      Perrigo
      Boehringer Ingelheim
      Purdue Pharma
      C.B. Fleet
      Abbott
      Jiangzhong
      Xian-Janssen

      In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

      Research objectives
      To study and analyze the global Gastrointestinal Drugs consumption (value & volume) by key regions/countries, product type and application, history data from 2013 to 2017, and forecast to 2023.
      To understand the structure of Gastrointestinal Drugs market by identifying its various subsegments.
      Focuses on the key global Gastrointestinal Drugs manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
      To analyze the Gastrointestinal Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.
      To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
      To project the consumption of Gastrointestinal Drugs submarkets, with respect to key regions (along with their respective key countries).
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
      To strategically profile the key players and comprehensively analyze their growth strategies.


      Summary:
      Get latest Market Research Reports on Gastrointestinal Drugs . Industry analysis & Market Report on Gastrointestinal Drugs is a syndicated market report, published as 2018-2023 Global Gastrointestinal Drugs Consumption Market Report. It is complete Research Study and Industry Analysis of Gastrointestinal Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $4,660.00
      $6,990.00
      $9,320.00
      3,662.34
      5,493.50
      7,324.67
      4,093.41
      6,140.12
      8,186.83
      499,412.20
      749,118.30
      998,824.40
      323,193.37
      484,790.05
      646,386.74
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report